[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @jeromeleonard5 jerome leonard jerome leonard posts on X about $tngx, $idya, mono, $imcr the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::2574682512/interactions)  - X Week XXXXX +4.50% - X Month XXXXXX -XX% - X Months XXXXXX -XX% - X Year XXXXXXX +2,208% ### Mentions: XX [#](/creator/twitter::2574682512/posts_active)  - X Week XX +79% - X Month XX +37% - X Months XXX -XX% - X Year XXX +1,942% ### Followers: XXXXX [#](/creator/twitter::2574682512/followers)  - X Week XXXXX +0.22% - X Month XXXXX +0.89% - X Months XXXXX +5.90% - X Year XXXXX +13% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::2574682512/influencer_rank)  ### Social Influence [#](/creator/twitter::2574682512/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXX% [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$tngx](/topic/$tngx) #2, [$idya](/topic/$idya) #4, [mono](/topic/mono) #184, [$imcr](/topic/$imcr) 2.94%, [one a](/topic/one-a) 1.47%, [6m](/topic/6m) 1.47%, [has been](/topic/has-been) 1.47%, [$cere](/topic/$cere) 1.47%, [take the](/topic/take-the) 1.47%, [cere](/topic/cere) XXXX% **Top accounts mentioned or mentioned by** [@bioinvestor24](/creator/undefined) [@avidresearch](/creator/undefined) [@notgenentech](/creator/undefined) [@jacobplieth](/creator/undefined) [@biovalues](/creator/undefined) [@biotechport](/creator/undefined) [@bigpharmaguy](/creator/undefined) [@biotechobserver](/creator/undefined) [@dmitrykovalchuk](/creator/undefined) [@nociftw](/creator/undefined) [@pikacapital](/creator/undefined) [@semodough](/creator/undefined) [@notthatkindofdr](/creator/undefined) [@amylucio2009](/creator/undefined) [@17thfellow](/creator/undefined) [@stl_biotech](/creator/undefined) [@sanctuarybio](/creator/undefined) [@ivaj960612](/creator/undefined) [@pharminghunting](/creator/undefined) [@ltbioinvestor](/creator/undefined) **Top assets mentioned** [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Cere Network (CERE)](/topic/$cere) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [GSK plc (GSK)](/topic/$gsk) ### Top Social Posts [#](/creator/twitter::2574682512/posts) --- Top posts by engagements in the last XX hours "@MaverickNY @BiotechStrategy 300m series c in this market was a 50m one a year ago. Still 🍿 time at esmo" [X Link](https://x.com/jeromeleonard5/status/1978530514559463839) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-15T18:36Z 2274 followers, XXX engagements "@bioinvestor24 And yes $idya will rule over mtap and it won't even be close. But there will always be gbm. 😘" [X Link](https://x.com/jeromeleonard5/status/1967998892106191051) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-16T17:07Z 2274 followers, XXX engagements "@bioinvestor24 @NotGenentech XXX has +30% ORR and +6m mfs isn't this what you and $tngx ceo are wishing for XXX Only difference is that $idya ceo doesn't think this warrants a mono P3. And yes low N but if you look at ORR & how fast those resp are happening its a clear proof of synergies as intended" [X Link](https://x.com/jeromeleonard5/status/1972008978671693887) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-27T18:42Z 2274 followers, XXX engagements "@bioinvestor24 @NotGenentech No they didnt. Prmt5 add on has been in the pipe for a long time. Again there hasnt been any mono prmt5 agent that has been pushed for mono approval. Im sure XXX is very special yet ceo comments they are aspiring for same orr as the bmy compound. Differentiation" [X Link](https://x.com/jeromeleonard5/status/1972012804850036912) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-27T18:57Z 2274 followers, XXX engagements "At least $cere management was smart enough to take the $ when they could" [X Link](https://x.com/jeromeleonard5/status/1972371841584169019) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-28T18:44Z 2274 followers, 2328 engagements "$bmy prmt5 going after 1L mtap Pdac $tngx Study named: Moutain-TAP30 😆" [X Link](https://x.com/jeromeleonard5/status/1976152404081950943) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-09T05:07Z 2274 followers, 1782 engagements "Looks like servier is trying to pair their mat2a inhibitor with $tngx prmt5. Aiming at X indications: pdac gastroesophageal and btc" [X Link](https://x.com/jeromeleonard5/status/1976155914886332603) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-09T05:20Z 2274 followers, 1077 engagements "$tngx degenerates are back at it again. Meanwhile mpfs still has to stew some more because ballpark bmy orr isnt going to cut it" [X Link](https://x.com/jeromeleonard5/status/1977780031217615092) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-13T16:54Z 2274 followers, XXX engagements "@BiotechSage @semodough Stop using $imcr trial as comp. It is useless" [X Link](https://x.com/jeromeleonard5/status/1979425301793816905) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-18T05:52Z 2274 followers, XXX engagements "@JoseRestonVA @princetongb Id like to see that mtap deal with Roche materialise. And let then take a stake in $idya in the mid to high 40s on top of it. Could end up with nearly 2b in cash and a break even horizon in 27" [X Link](https://x.com/jeromeleonard5/status/1979595307152253086) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-18T17:07Z 2275 followers, 2159 engagements "$gsk prmt5 bites the dust" [X Link](https://x.com/jeromeleonard5/status/1968285534989750769) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-17T12:06Z 2271 followers, 2201 engagements "@NotthatkindofDr @JacobPlieth Id wait for the gsk update before drawing any conclusions on wrn. Data will be better than roche" [X Link](https://x.com/jeromeleonard5/status/1977720701680242965) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-13T12:58Z 2272 followers, XXX engagements "@BigChodu XX% SI explains the ramp. 800m EV for a pre P2 onc company is frotty. High bar for differentiation for XXX vs bmy. As for the brain penetrant prmt5 gbm is Mount Everest but here no one made it past base camp. Funded for another X quarters so they need $ 25/30% dilution coming" [X Link](https://x.com/jeromeleonard5/status/1979073077171380239) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-17T06:32Z 2270 followers, XXX engagements "ORR dropping from a cliff for 3rd line + patients should make it clear which one has the best eff. If we focus on the XXX dose $zlab is losing very deep resp pretty fast. For me the gr3 ae profile just look too good and this will come at cost of exposure levels & durability" [X Link](https://x.com/jeromeleonard5/status/1965424142859264078) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-09T14:36Z 2274 followers, 1290 engagements "@17thfellow @belowcashbuyer Yes silly protections based on $imcr phase X results. Which was mostly a censoring craftsmanship wonder" [X Link](https://x.com/jeromeleonard5/status/1978871461034049813) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-16T17:11Z 2274 followers, XXX engagements "@semodough I hope theyll provide a complete km curve of os events so we can compare how many of total N were still on trial by the time of that mOS event. For kimmtrak it was 33/252 or 13%" [X Link](https://x.com/jeromeleonard5/status/1979635910686711823) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-18T19:49Z 2274 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@jeromeleonard5 jerome leonard
jerome leonard posts on X about $tngx, $idya, mono, $imcr the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX +4.50%
- X Month XXXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXXX +2,208%
Mentions: XX #
- X Week XX +79%
- X Month XX +37%
- X Months XXX -XX%
- X Year XXX +1,942%
Followers: XXXXX #
- X Week XXXXX +0.22%
- X Month XXXXX +0.89%
- X Months XXXXX +5.90%
- X Year XXXXX +13%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence cryptocurrencies XXXX% stocks XXXX% finance XXXX% travel destinations XXXX%
Social topic influence $tngx #2, $idya #4, mono #184, $imcr 2.94%, one a 1.47%, 6m 1.47%, has been 1.47%, $cere 1.47%, take the 1.47%, cere XXXX%
Top accounts mentioned or mentioned by @bioinvestor24 @avidresearch @notgenentech @jacobplieth @biovalues @biotechport @bigpharmaguy @biotechobserver @dmitrykovalchuk @nociftw @pikacapital @semodough @notthatkindofdr @amylucio2009 @17thfellow @stl_biotech @sanctuarybio @ivaj960612 @pharminghunting @ltbioinvestor
Top assets mentioned IDEAYA Biosciences, Inc. Common Stock (IDYA) Cere Network (CERE) Bristol-Myers Squibb Co (BMY) GSK plc (GSK)
Top Social Posts #
Top posts by engagements in the last XX hours
"@MaverickNY @BiotechStrategy 300m series c in this market was a 50m one a year ago. Still 🍿 time at esmo"
X Link @jeromeleonard5 2025-10-15T18:36Z 2274 followers, XXX engagements
"@bioinvestor24 And yes $idya will rule over mtap and it won't even be close. But there will always be gbm. 😘"
X Link @jeromeleonard5 2025-09-16T17:07Z 2274 followers, XXX engagements
"@bioinvestor24 @NotGenentech XXX has +30% ORR and +6m mfs isn't this what you and $tngx ceo are wishing for XXX Only difference is that $idya ceo doesn't think this warrants a mono P3. And yes low N but if you look at ORR & how fast those resp are happening its a clear proof of synergies as intended"
X Link @jeromeleonard5 2025-09-27T18:42Z 2274 followers, XXX engagements
"@bioinvestor24 @NotGenentech No they didnt. Prmt5 add on has been in the pipe for a long time. Again there hasnt been any mono prmt5 agent that has been pushed for mono approval. Im sure XXX is very special yet ceo comments they are aspiring for same orr as the bmy compound. Differentiation"
X Link @jeromeleonard5 2025-09-27T18:57Z 2274 followers, XXX engagements
"At least $cere management was smart enough to take the $ when they could"
X Link @jeromeleonard5 2025-09-28T18:44Z 2274 followers, 2328 engagements
"$bmy prmt5 going after 1L mtap Pdac $tngx Study named: Moutain-TAP30 😆"
X Link @jeromeleonard5 2025-10-09T05:07Z 2274 followers, 1782 engagements
"Looks like servier is trying to pair their mat2a inhibitor with $tngx prmt5. Aiming at X indications: pdac gastroesophageal and btc"
X Link @jeromeleonard5 2025-10-09T05:20Z 2274 followers, 1077 engagements
"$tngx degenerates are back at it again. Meanwhile mpfs still has to stew some more because ballpark bmy orr isnt going to cut it"
X Link @jeromeleonard5 2025-10-13T16:54Z 2274 followers, XXX engagements
"@BiotechSage @semodough Stop using $imcr trial as comp. It is useless"
X Link @jeromeleonard5 2025-10-18T05:52Z 2274 followers, XXX engagements
"@JoseRestonVA @princetongb Id like to see that mtap deal with Roche materialise. And let then take a stake in $idya in the mid to high 40s on top of it. Could end up with nearly 2b in cash and a break even horizon in 27"
X Link @jeromeleonard5 2025-10-18T17:07Z 2275 followers, 2159 engagements
"$gsk prmt5 bites the dust"
X Link @jeromeleonard5 2025-09-17T12:06Z 2271 followers, 2201 engagements
"@NotthatkindofDr @JacobPlieth Id wait for the gsk update before drawing any conclusions on wrn. Data will be better than roche"
X Link @jeromeleonard5 2025-10-13T12:58Z 2272 followers, XXX engagements
"@BigChodu XX% SI explains the ramp. 800m EV for a pre P2 onc company is frotty. High bar for differentiation for XXX vs bmy. As for the brain penetrant prmt5 gbm is Mount Everest but here no one made it past base camp. Funded for another X quarters so they need $ 25/30% dilution coming"
X Link @jeromeleonard5 2025-10-17T06:32Z 2270 followers, XXX engagements
"ORR dropping from a cliff for 3rd line + patients should make it clear which one has the best eff. If we focus on the XXX dose $zlab is losing very deep resp pretty fast. For me the gr3 ae profile just look too good and this will come at cost of exposure levels & durability"
X Link @jeromeleonard5 2025-09-09T14:36Z 2274 followers, 1290 engagements
"@17thfellow @belowcashbuyer Yes silly protections based on $imcr phase X results. Which was mostly a censoring craftsmanship wonder"
X Link @jeromeleonard5 2025-10-16T17:11Z 2274 followers, XXX engagements
"@semodough I hope theyll provide a complete km curve of os events so we can compare how many of total N were still on trial by the time of that mOS event. For kimmtrak it was 33/252 or 13%"
X Link @jeromeleonard5 2025-10-18T19:49Z 2274 followers, XXX engagements